| 早期瑞舒伐他汀干预对不稳定型心绞痛支架术后血清妊娠相关蛋白A和高敏C反应蛋白的影响 |
| |
| 引用本文： | 翁建新,刘强,左辉华,王丽丽,张敏州,魏熠,陈绮映. 早期瑞舒伐他汀干预对不稳定型心绞痛支架术后血清妊娠相关蛋白A和高敏C反应蛋白的影响[J]. 中西医结合心脑血管病杂志, 2011, 9(7) |
| |
| 作者姓名： | 翁建新 刘强 左辉华 王丽丽 张敏州 魏熠 陈绮映 |
| |
| 作者单位： | 1. 深圳市心血管病研究所,518102
2. 广东省中医院 |
| |
| 摘 要： | 目的 探讨瑞舒伐他汀对血脂水平正常的不稳定型心绞痛患者行PCI术后妊娠相关蛋白A(PAPP-A)及高敏C反应蛋白(hs-CRP)的影响.方法 56例血脂水平正常的不稳定型心绞痛患者,随机分为瑞舒伐他汀组和常规治疗组,两组患者分别于PCI术前、术后24 h、术后1个月检测血清PAPP-A 和hs-CRP水平.结果 两组患者术后24 h与术前比较,血清PAPP-A和hs-CRP浓度均有明显升高,但两组间比较,无明显差异;术后1个月,两组血清PAPP-A 和hs-CRP水平与术后24 h比较,均有回降,但瑞舒伐他汀组较常规治疗组回降更为明显,两者存在统计学意义(P<0.05).结论 早期使用瑞舒伐他汀能更有效降低不稳定型心绞痛患者PCI术后PAPP-A和hs-CRP水平.
|
| 关 键 词： | 瑞舒伐他汀 不稳定型心绞痛 妊娠相关蛋白A 高敏C反应蛋白 经皮冠脉介入治疗 |
Influence of Rosuvastatain on Plasma PAPP-A and hs-CRP after PCI in Unstable Angina Pectoris |
| |
| Weng Jianxin,Liu Qiang,Zou Huihua,et al Sun Yatsen Cardiovascular Hospital,Shenzhen. Influence of Rosuvastatain on Plasma PAPP-A and hs-CRP after PCI in Unstable Angina Pectoris[J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2011, 9(7) |
| |
| Authors: | Weng Jianxin Liu Qiang Zou Huihua et al Sun Yatsen Cardiovascular Hospital Shenzhen |
| |
| Affiliation: | Weng Jianxin,Liu Qiang,Zou Huihua,et al Sun Yatsen Cardiovascular Hospital,Shenzhen(Shenzhen 518102) |
| |
| Abstract: | Objective To investigate the effects of rosuvastatain on the pregnancy-associated plasma protein-A(PAPP-A) and high sensitivity C-reactive protein(hs-CRP) after percutaneous coronary intervention(PCI) in patients(pts) with unstable angina pectoris(UAP).Methods Fifty-six pts with UAP were randomly divided into two groups:Rosuvastatain group(n=30) treated with rosuvastatain and control group(n=26) treated with routine treatment.The levels of PAPP-A and hs-CRP were detected before PCI and at 24 hours,1 month a... |
| |
| Keywords: | Rosuvastatain unstable angina pectoris pregnancy-associated plasma protein-A high sensitivity C-reactive protein percutaneous coronary intervention |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
